¼¼°èÀÇ ¼Ò¿Ü¿­´ë¼ºÁúȯ Ä¡·á ½ÃÀå º¸°í¼­(2025³â)
Neglected Tropical Disease Treatment Global Market Report 2025
»óǰÄÚµå : 1769669
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,310,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,121,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,932,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼Ò¿Ü¿­´ë¼ºÁúȯ Ä¡·á ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â°£ °­ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2029³â¿¡´Â CAGR 6.1%·Î 45¾ï 2,000¸¸ ´Þ·¯·Î ¼ºÀåÇÒ Àü¸ÁÀÔ´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ÁÖ¿ä ¼ºÀå µ¿·ÂÀ¸·Î´Â Áúº´ ¸ð´ÏÅ͸µÀ» À§ÇÑ µðÁöÅÐ µµ±¸ÀÇ »ç¿ë È®´ë, ½Å¾à ¹× ¹é½ÅÀÇ ÆÄÀÌÇÁ¶óÀÎ È®´ë, Ç×»ýÁ¦ ³»¼º ¿ì·ÁÀÇ °íÁ¶, Áúº´ ÅëÁ¦¸¦ À§ÇÑ ±¹°æ °£ Çù·Â °­È­, ±âÈÄ º¯È­°¡ Áúº´ È®»ê¿¡ ¹ÌÄ¡´Â ¿µÇâ µîÀÌ ÀÖ½À´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â ÇöÁöÈ­µÈ Ä¡·á Àü·«ÀÇ °³¹ß, Àú·ÅÇÑ ¹é½Å Ç÷§Æû, 1Â÷ ÀÇ·á ¼­ºñ½º¿ÍÀÇ ÅëÇÕ, Áúº´ °¨½Ã ³×Æ®¿öÅ©ÀÇ È®´ë, ¸Å°³Ã¼ ¹æÁ¦ ±â¼úÀÇ Çõ½Å µîÀÌ ÀÖ½À´Ï´Ù.

°¨¿°¼º Áúº´ÀÇ À¯ÇàÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÇâÈÄ ¸î ³â µ¿¾È ¼ÒȦÈ÷ ¿©°ÜÁö´Â ¿­´ë Áúº´ Ä¡·á ½ÃÀåÀÌ ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. °¨¿°¼º Áúº´Àº ¹ÚÅ׸®¾Æ, ¹ÙÀÌ·¯½º, °õÆÎÀÌ, ±â»ýÃæ°ú °°Àº À¯ÇØÇÑ ¹Ì»ý¹°¿¡ ÀÇÇØ ¹ß»ýÇÏ´Â Áúº´À¸·Î, ÇÑ »ç¶÷¿¡¼­ ´Ù¸¥ »ç¶÷À¸·Î Á÷Á¢ ¶Ç´Â °£Á¢ÀûÀ¸·Î Àü¿°µÉ ¼ö ÀÖ½À´Ï´Ù. °¨¿°¼º Áúº´ÀÇ Áõ°¡´Â ÁÖ·Î Àü ¼¼°è ¿©ÇàÀÇ Áõ°¡·Î ÀÎÇØ ±¹°æÀ» ³Ñ¾î º´¿ø±ÕÀÌ ºü¸£°Ô ÀüÆÄµÇ±â ¶§¹®À¸·Î º¸ÀÔ´Ï´Ù. ¼Ò¿Ü¿­´ë¼ºÁúȯ Ä¡·á´Â ÀÌ·¯ÇÑ Áúº´ÀÇ È®»êÀ» ÅëÁ¦ÇÏ°í ±ÙÀýÇÏ´Â µ¥ ÇʼöÀûÀÎ ¸ÂÃãÇü Ä¡·á¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Ä¡·á¹ýÀº Ãë¾à °èÃþ¿¡¼­ Áúº´ ºÎ´ãÀ» ÁÙÀ̰í Àå±âÀû Àå¾Ö¸¦ ¿¹¹æÇÔÀ¸·Î½á °øÁß º¸°Ç °á°ú¸¦ °³¼±ÇÏ´Â µ¥ ƯÈ÷ È¿°úÀûÀÔ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 2¿ù ¿µ±¹ º¸°Ç º¸¾Èû(UK Health Security Agency)Àº 2023³â ¿µ±¹¿¡¼­ °áÇ٠ȯÀÚ ¼ö°¡ 4,850¸íÀ¸·Î 2022³â 4,380¸í¿¡¼­ 10.7% Áõ°¡Çß´Ù°í º¸°íÇß½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀº Àü¿°º´ÀÇ À¯ÇàÀÌ Áõ°¡Çϸ鼭 ¼ÒȦÈ÷ ¿©°ÜÁö´Â ¿­´ë¼º Áúº´ Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ½À» º¸¿©ÁÝ´Ï´Ù.

¼Ò¿Ü¿­´ë¼ºÁúȯ Ä¡·á ½ÃÀåÀÇ ±â¾÷µéÀº ¿¬±¸ °³¹ßÀ» °­È­Çϰí, Àü ¼¼°è¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» È®´ëÇϸç, Çõ½ÅÀûÀÎ Ä¡·á¹ýÀ» ¹ßÀü½Ã۱â À§ÇØ Àü·«Àû ÅõÀÚ¸¦ °­Á¶Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÅõÀڴ ÷´Ü ¿¬±¸¸¦ Áö¿øÇϰí, Çù·ÂÀ» Àå·ÁÇϸç, ¼Ò¿ÜµÈ °èÃþÀ» À§ÇÑ Àú·ÅÇϰí È¿°úÀûÀÎ Ä¡·á¹ýÀÇ °³¹ßÀ» ÃËÁøÇÔÀ¸·Î½á ½ÃÀå ¼ºÀå¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 6¿ù ½ºÀ§½º ±â¹Ý Á¦¾à ±â¾÷ ³ë¹ÙƼ½º AG´Â ¼Ò¿Ü¿­´ë¼ºÁúȯ(NTD)°ú ¸»¶ó¸®¾Æ¿ÍÀÇ ½Î¿òÀ» À§ÇØ 2¾ï 5,000¸¸ ´Þ·¯¸¦ ÅõÀÚÇϱâ·Î ¾à¼ÓÇß½À´Ï´Ù. ÀÌ ÀÚ±ÝÀº Àú¼Òµæ Áö¿ª¿¡¼­ÀÇ Ä¡·áÁ¦ Á¢±Ù¼ºÀ» ³ôÀ̰í ÀÌ·¯ÇÑ ÁúȯÀ» À§ÇÑ »õ·Î¿î Ä¡·á¹ý °³¹ßÀ» Áö¿øÇϱâ À§ÇØ »ç¿ëµÉ ¿¹Á¤ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå : ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ªÀüÀï°ú °ü¼¼, ±×¸®°í Äڷγª 19 ¹× ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°, ±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Neglected tropical disease (NTD) treatment refers to medical interventions aimed at controlling, eliminating, or eradicating a group of infectious diseases that predominantly impact impoverished populations in tropical and subtropical areas. The primary objective of these treatments is to reduce the disease burden, prevent disability, and enhance the quality of life within affected communities.

The primary drug classes utilized in treating neglected tropical diseases include anti-parasitic agents, antifungals, antibiotics, and others. Anti-parasitic agents are substances or treatments intended to prevent, kill, or eliminate parasites that infect humans, animals, or plants. These treatments address a range of diseases such as leishmaniasis, schistosomiasis, lymphatic filariasis, Chagas disease, African trypanosomiasis, and others. The drugs are administered either orally or parenterally and are distributed through various channels, including hospital pharmacies, retail pharmacies, and online pharmacies. These treatments cater to multiple end users, such as hospitals, specialty clinics, homecare settings, and more.

The neglected tropical disease treatment market research report is one of a series of new reports from The Business Research Company that provides neglected tropical disease treatment market statistics, including the neglected tropical disease treatment industry's global market size, regional shares, competitors with the neglected tropical disease treatment market share, detailed neglected tropical disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the neglected tropical disease treatment market. This neglected tropical disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The neglected tropical disease treatment market size has grown strongly in recent years. It will grow from $3.36 billion in 2024 to $3.57 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. This historical growth is attributed to a greater government focus on disease elimination programs, expanding public-private partnerships for drug donations, rising pharmaceutical donations from global manufacturers, increasing research into low-cost antiparasitic therapies, and growing investments in vaccine and diagnostic development.

The neglected tropical disease treatment market size is expected to see strong growth in the next few years. It will grow to $4.52 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. Key growth drivers in the forecast period include the expanded use of digital tools for disease monitoring, a growing pipeline of new drugs and vaccines, rising concerns about antimicrobial resistance, enhanced cross-border collaboration for disease control, and the influence of climate change on disease spread. Notable trends expected in the forecast period include the development of localized treatment strategies, affordable vaccine platforms, integration with primary healthcare services, expansion of disease surveillance networks, and innovations in vector control technologies.

The increasing prevalence of infectious diseases is anticipated to drive the growth of the neglected tropical disease treatment market in the coming years. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites, which can spread from one person to another either directly or indirectly. This rise in infectious diseases is primarily attributed to increased global travel, which accelerates the transmission of pathogens across borders. Neglected tropical disease treatment plays a crucial role by offering targeted therapies that help control and eliminate the spread of these diseases. These treatments are particularly beneficial in vulnerable communities, where they improve public health outcomes by reducing disease burden and preventing long-term disabilities. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased to 4,850 in 2023, a 10.7% rise from 4,380 cases in 2022. This trend highlights how the growing prevalence of infectious diseases is fueling the demand for neglected tropical disease treatments.

Companies in the neglected tropical disease treatment market are emphasizing strategic investments to strengthen research and development, broaden global access, and advance innovative therapies. These investments contribute significantly to market growth by supporting advanced research, encouraging collaborations, and expediting the creation of affordable and effective treatments for underserved populations. For instance, in June 2022, Novartis AG, a pharmaceutical corporation based in Switzerland, committed $250 million toward combating neglected tropical diseases (NTDs) and malaria. This funding aims to make treatments more accessible in low-income regions and to support the development of new therapies for these diseases.

In August 2022, Dr. Reddy's Laboratories Ltd., an India-based pharmaceutical company, and Aurigene Pharmaceutical Services Limited, also based in India, collaborated with the Drugs for Neglected Diseases initiative (DNDi) to develop, manufacture, and commercialize new treatments for neglected tropical diseases. This partnership is intended to speed up the development of affordable and accessible therapies, addressing the unmet medical needs in low- and middle-income countries. The DNDi, headquartered in Switzerland, is a non-profit organization dedicated to developing effective and affordable treatments for neglected tropical diseases.

Major players in the neglected tropical disease treatment market are Pfizer Inc., Johnson And Johnson, Merck And Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., AstraZeneca PLC, Abbott Laboratories, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., Eisai Co. Ltd., Shionogi And Co. Ltd., Dr. Reddy's Laboratories Ltd, Cipla Ltd., Eiken Chemical Company Ltd, LifeArc, Atomwise Inc., and Medicines Development for Global Health Ltd.

Asia Pacific was the largest region in the neglected tropical disease treatment market in 2024. The regions covered in neglected tropical disease treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the neglected tropical disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The neglected tropical disease treatment market consists of revenues earned by entities by providing services such as mass drug administration, disease surveillance, diagnostic testing, patient care and management, health education, and vector control programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The neglected tropical disease (NTD) treatment market also includes sales of diagnostic kits, vaccines, insecticides, and medical devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Neglected Tropical Disease Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on neglected tropical disease treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for neglected tropical disease treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The neglected tropical disease treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Neglected Tropical Disease Treatment Market Characteristics

3. Neglected Tropical Disease Treatment Market Trends And Strategies

4. Neglected Tropical Disease Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Neglected Tropical Disease Treatment Growth Analysis And Strategic Analysis Framework

6. Neglected Tropical Disease Treatment Market Segmentation

7. Neglected Tropical Disease Treatment Market Regional And Country Analysis

8. Asia-Pacific Neglected Tropical Disease Treatment Market

9. China Neglected Tropical Disease Treatment Market

10. India Neglected Tropical Disease Treatment Market

11. Japan Neglected Tropical Disease Treatment Market

12. Australia Neglected Tropical Disease Treatment Market

13. Indonesia Neglected Tropical Disease Treatment Market

14. South Korea Neglected Tropical Disease Treatment Market

15. Western Europe Neglected Tropical Disease Treatment Market

16. UK Neglected Tropical Disease Treatment Market

17. Germany Neglected Tropical Disease Treatment Market

18. France Neglected Tropical Disease Treatment Market

19. Italy Neglected Tropical Disease Treatment Market

20. Spain Neglected Tropical Disease Treatment Market

21. Eastern Europe Neglected Tropical Disease Treatment Market

22. Russia Neglected Tropical Disease Treatment Market

23. North America Neglected Tropical Disease Treatment Market

24. USA Neglected Tropical Disease Treatment Market

25. Canada Neglected Tropical Disease Treatment Market

26. South America Neglected Tropical Disease Treatment Market

27. Brazil Neglected Tropical Disease Treatment Market

28. Middle East Neglected Tropical Disease Treatment Market

29. Africa Neglected Tropical Disease Treatment Market

30. Neglected Tropical Disease Treatment Market Competitive Landscape And Company Profiles

31. Neglected Tropical Disease Treatment Market Other Major And Innovative Companies

32. Global Neglected Tropical Disease Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Neglected Tropical Disease Treatment Market

34. Recent Developments In The Neglected Tropical Disease Treatment Market

35. Neglected Tropical Disease Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â